v3.24.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 344,011 $ 375,529
Reconciling items:    
Depreciation 146,168 127,670
Amortization 124,155 124,029
Amortization of non-recoupable ticketing contract advances 45,241 41,597
Deferred income tax expense (benefit) (6,078) 5,430
Amortization of debt issuance costs and discounts 7,881 8,949
Loss on extinguishment of debt 0 18,366
Stock-based compensation expense 59,738 55,333
Unrealized changes in fair value of contingent consideration (28,573) 20,100
Gain on mark-to-market of investments in nonconsolidated affiliates (100,153) (26,408)
Equity in losses of nonconsolidated affiliates, net of distributions 5,671 9,019
Provision for uncollectible accounts receivable (9,806) 20,120
Other, net (11,972) (512)
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Increase in accounts receivable (436,458) (395,516)
Increase in prepaid expenses and other assets (646,147) (836,672)
Increase in accounts payable, accrued expenses and other liabilities 391,059 298,718
Increase in deferred revenue 1,516,217 1,801,097
Net cash provided by operating activities 1,400,954 1,646,849
CASH FLOWS FROM INVESTING ACTIVITIES    
Advances of notes receivable (75,973) (118,973)
Collections of notes receivable 21,290 8,286
Investments made in nonconsolidated affiliates (30,593) (26,336)
Purchases of property, plant and equipment (333,689) (202,531)
Cash acquired from (paid for) acquisitions, net of cash paid (acquired) (17,579) 69,359
Purchases of intangible assets (5,390) (35,088)
Other, net 7,529 6,077
Net cash used in investing activities (434,405) (299,206)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from long-term debt, net of debt issuance costs 886 986,766
Payments on long-term debt (377,132) (614,030)
Contributions from noncontrolling interests 28 14,716
Distributions to noncontrolling interests (171,908) (137,609)
Purchases of noncontrolling interests, net (47,980) (88,239)
Proceeds from sale of common stock, net of issuance costs 0 (75,500)
Proceeds from exercise of stock options 12,819 4,999
Taxes paid for net share settlement of equity awards (38,551) (8,464)
Payments for deferred and contingent consideration (20,390) (9,440)
Other, net (748) 315
Net cash provided by (used in) financing activities (642,976) 73,514
Effect of exchange rate changes on cash, cash equivalents and restricted cash (152,989) 103,111
Net increase in cash, cash equivalents, and restricted cash 170,584 1,524,268
Cash, cash equivalents and restricted cash at beginning of period 6,238,956 5,612,374
Cash, cash equivalents and restricted cash at end of period $ 6,409,540 $ 7,136,642

Source